These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7025255)

  • 1. Who is a biomedical engineer?
    S Afr Med J; 1981 Sep; 60(10):374. PubMed ID: 7025255
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilator and antiplatelet activities of prostacyclins with modified omega-side chain.
    Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
    Adv Prostaglandin Thromboxane Res; 1980; 6():341-5. PubMed ID: 6992533
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostacyclin and blood coagulation.
    Moncada S; Vane JR
    Drugs; 1981 Jun; 21(6):430-7. PubMed ID: 7018874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation].
    Fabiani JN; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C
    Arch Mal Coeur Vaiss; 1982 Mar; 75(3):241-8. PubMed ID: 6807240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
    Ubatuba FB; Moncada S; Vane JR
    Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostaglandins and arteriosclerosis. Action of PGI 2 (PGX) on platelet aggregation].
    Messini M; Messini F
    Clin Ter; 1979 Jul; 90(1):3-9. PubMed ID: 394908
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of PGI2 infusion during long term extracorporeal circulation with membrane lung in sheep.
    Uziel L; Agostoni A; Pirovano E; Pesenti A; Pelizzola A; Gattinoni L; Galmarini D
    Int J Artif Organs; 1981 May; 4(3):142-5. PubMed ID: 7024139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostacyclin--inhibitory effect on thrombocyte aggregation on the vascular wall in vivo?].
    Sinzinger H; Silberbauer K; Winter M
    Vasa; 1978; 7(4):350-9. PubMed ID: 364866
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of controlled release of prostaglandin from polymer matrices for thrombus prevention.
    McRea JC; Kim SW
    Trans Am Soc Artif Intern Organs; 1978; 24():746-52. PubMed ID: 362677
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
    Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
    [No Abstract]   [Full Text] [Related]  

  • 11. [The action of thromboxanes and prostacyclins on platelet function].
    Nechifor M
    Rev Med Chir Soc Med Nat Iasi; 1980; 84(1):15-9. PubMed ID: 6994194
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergism between prostacyclin (PGI2) and prazosin on human platelet aggregation.
    Moore PK
    Thromb Haemost; 1982 Feb; 47(1):76. PubMed ID: 7041326
    [No Abstract]   [Full Text] [Related]  

  • 13. Epoprostenol now the focus of numerous clinical trials.
    Check WA
    JAMA; 1981 Jun; 245(24):2481-3. PubMed ID: 7014954
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
    Bult H; Wechsung E; Houvenaghel A; Herman AG
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
    Dembinska-Kiec A; Rücker W; Schönhöfer PS; Gandolfi C
    Thromb Haemost; 1979 Dec; 42(4):1340-3. PubMed ID: 232318
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergic effect of prostacyclin (PGI2) and alpha-blocking-agent on adrenalin-induced human platelet aggregation.
    Pogliani E; Fantasia R; Colombi M; Praga C
    Thromb Haemost; 1980 Oct; 44(2):106. PubMed ID: 6109380
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of PGI2 on platelet aggregation induced by various stimulants.
    Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-platelet aggregation effect of PGI2 potentiated by EG-626].
    Tanaka K; Harada Y; Katori M
    Rinsho Byori; 1979; Suppl 40():188-91. PubMed ID: 399308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.